Search Result "CC-5013"
Current Status of Thalidomide and CC-5013 in the Treatment of Metastatic Prostate Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2009 Page: 1058-1069
Author(s): Tristan M. Sissung, Silja Thordardottir, Erin R. Gardner, William D. Figg
Immunomodulatory Drugs as a Therapy for Multiple Myeloma
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 6 Year: 2006 Page: 415-421
Author(s): H. De Raeve, K. Vanderkerken
Thalidomide Analogues as Anticancer Drugs
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2 Issue: 2 Year: 2007 Page: 167-174
Author(s): Jeanny B. Aragon-Ching, Haiqing Li, Erin R. Gardner, William D. Figg
Lenalidomide: Cancer Therapy via Antiangiogenesis and Immunomodulation
Journal: Current Cancer Therapy Reviews
Volume: 2 Issue: 3 Year: 2006 Page: 223-229
Author(s): Tanyifor M. Tohny, Jurgen Venitz, Alex Sparreboom, William D. Figg
Pharmacological Properties of Thalidomide and its Analogues
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 4 Issue: 2 Year: 2010 Page: 144-148
Author(s): Juan B. De Sanctis, Michael Mijares, Alirica Suarez, Reinaldo Compagnone, Jenny Garmendia, Dolores Moreno, Margarita Salazar-Bookaman
Immunomodulatory Drugs (IMiDs™): A New Treatment Option for Myelodysplastic Syndromes
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 5 Year: 2006 Page: 339-342
Author(s): Vishakha Kale, Alan F. List
Immunomodulatory Properties of Thalidomide Analogs: Pomalidomide and Lenalidomide, Experimental and Therapeutic Applications
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5 Issue: 3 Year: 2011 Page: 192-196
Author(s): Pawel Bodera, Wanda Stankiewicz
Thalidomide Chemotherapy-Induced Peripheral Neuropathy: Actual Status and New Perspectives with Thalidomide Analogues Derivatives
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9 Issue: 7 Year: 2009 Page: 760-768
Author(s): Sante Cundari, Guido Cavaletti
Novel Antiangiogenic Molecules in Multiple Myeloma
Ebook: Recent Advances in Angiogenesis and Antiangiogenesis
Volume: 1 Year: 2009
Author(s): Aldo M. Roccaro,Irene M. Ghobrial
Doi: 10.2174/978160805004810901010127
Thalidomide Derived Immunomodulatory Drugs (IMiDs) as Potential Therapeutic Agents
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 3 Issue: 3 Year: 2003 Page: 181-186
Author(s): J Blake Marriott, Keith Dredge, Angus G. Dalgleish